Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 2
1969 4
1970 2
1971 3
1972 3
1973 3
1974 3
1975 3
1976 1
1977 1
1978 2
1979 6
1980 1
1981 1
1982 3
1983 1
1984 2
1985 2
1986 1
1987 2
1988 3
1989 2
1990 2
1991 3
1992 1
1993 1
1994 1
1995 1
1996 1
1997 1
2000 1
2001 2
2003 3
2004 4
2005 3
2006 4
2007 3
2008 2
2010 1
2011 2
2015 5
2016 4
2017 4
2018 8
2019 5
2020 6
2021 3
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G. Venot Q, et al. Among authors: guibaud l. Nature. 2018 Jun;558(7711):540-546. doi: 10.1038/s41586-018-0217-9. Epub 2018 Jun 13. Nature. 2018. PMID: 29899452 Free PMC article. Clinical Trial.
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib.
Morin G, Degrugillier-Chopinet C, Vincent M, Fraissenon A, Aubert H, Chapelle C, Hoguin C, Dubos F, Catteau B, Petit F, Mezel A, Domanski O, Herbreteau G, Alesandrini M, Boddaert N, Boutry N, Broissand C, Han TK, Branle F, Sarnacki S, Blanc T, Guibaud L, Canaud G. Morin G, et al. Among authors: guibaud l. J Exp Med. 2022 Mar 7;219(3):e20212148. doi: 10.1084/jem.20212148. Epub 2022 Jan 26. J Exp Med. 2022. PMID: 35080595 Free PMC article.
[Hereditary hyperphosphatasia].
Guibaud P. Guibaud P. Pediatrie. 1970 Mar;25(2):235-8. Pediatrie. 1970. PMID: 5443278 French. No abstract available.
Toward clinical and molecular dissection of frontonasal dysplasia with facial skin polyps: From Pai syndrome to differential diagnosis through a series of 27 patients.
Lehalle D, Bruel AL, Vitobello A, Denommé-Pichon AS, Duffourd Y, Assoum M, Amiel J, Baujat G, Bessieres B, Bigoni S, Burglen L, Captier G, Dard R, Edery P, Fortunato F, Geneviève D, Goldenberg A, Guibaud L, Héron D, Holder-Espinasse M, Lederer D, Lopez Grondona F, Grotto S, Marlin S, Nadeau G, Picard A, Rossi M, Roume J, Sanlaville D, Saugier-Veber P, Triau S, Valenzuela Palafoll MI, Vanlerberghe C, Van Maldergem L, Vezain M, Vincent-Delorme C, Zivi E, Thevenon J, Vabres P, Thauvin-Robinet C, Callier P, Faivre L. Lehalle D, et al. Among authors: guibaud l. Am J Med Genet A. 2022 Jul;188(7):2036-2047. doi: 10.1002/ajmg.a.62739. Epub 2022 Apr 21. Am J Med Genet A. 2022. PMID: 35445792 Review.
Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G. Venot Q, et al. Among authors: guibaud l. Nature. 2019 Apr;568(7752):E6. doi: 10.1038/s41586-019-1109-3. Nature. 2019. PMID: 30944482
Development of a multi-hormone analysis method by LC-MS/MS for environmental water application using diffusive gradient in thin films.
Martins de Barros R, Lissalde S, Guibal R, Guibaud G. Martins de Barros R, et al. Among authors: guibaud g. Talanta. 2022 Jun 1;243:123390. doi: 10.1016/j.talanta.2022.123390. Epub 2022 Mar 14. Talanta. 2022. PMID: 35338929
Thirteen natural and synthetic hormones in ultra-pure water could be analysed in a single run according to the French Standard NF T90-210: calibration range of 0.1 (except for 17beta-Estradiol, Estriol, Estrone and Diethylstilbestrol, from 0.5 mug/L; and Ethinylestradiol, …
Thirteen natural and synthetic hormones in ultra-pure water could be analysed in a single run according to the French Standard NF T90-210: c …
Interest of a new large diffusive gradients in thin films (L-DGT) for organic compounds monitoring: On-field comparison with conventional passive samplers.
Martins de Barros R, Rougerie J, Guibal R, Lissalde S, Buzier R, Simon S, Guibaud G. Martins de Barros R, et al. Among authors: guibaud g. Environ Pollut. 2023 Apr 15;323:121257. doi: 10.1016/j.envpol.2023.121257. Epub 2023 Feb 22. Environ Pollut. 2023. PMID: 36828359
The POCIS provides the higher sensitivity, allowing the detection of more organic compounds compared to the DGT and, to a lesser extent, the L-DGT. However, both L-DGT and DGT reduces the uncertainty on the determination of the time-weighted average concentrations ( …
The POCIS provides the higher sensitivity, allowing the detection of more organic compounds compared to the DGT and, to a lesser extent, the …
Adaptation of the o-DGT for the sampling of 12 hormones: calibration, performance evaluation, and recommendation.
Martins de Barros R, Lissalde S, Guibal R, Guibaud G. Martins de Barros R, et al. Among authors: guibaud g. Environ Sci Pollut Res Int. 2023 Jun;30(26):68177-68190. doi: 10.1007/s11356-023-26975-6. Epub 2023 Apr 29. Environ Sci Pollut Res Int. 2023. PMID: 37119483
Therefore, the o-DGT configuration is suitable for sampling hormones in the natural environment with LOQ(DGT) ranging from 0.3 to 6.6 ng L(-1)....
Therefore, the o-DGT configuration is suitable for sampling hormones in the natural environment with LOQ(DGT) ranging from 0.3 to 6.6 ng …
118 results